Sleep Number (SNBR) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
1 Dec, 2025Executive summary
The company faced a historic industry recession in 2024, with inflation and weak consumer demand leading to the lowest U.S. mattress unit sales since 2015. Decisive actions included operational restructuring, cost reduction, and margin improvement initiatives to support free cash flow generation. Leadership changes were announced, with a new CEO, Linda Findley, appointed effective April 7, 2025, and a transition to an independent Chair of the Board. The company remains focused on financial resilience, margin improvement, and long-term value creation for shareholders.
Voting matters and shareholder proposals
Shareholders will vote on eight proposals: election of three directors, declassification of the board, elimination of supermajority voting requirements, ratification of Deloitte as independent auditor, advisory approval of executive compensation, amendment to the 2020 Equity Incentive Plan to add 500,000 shares, and potential adjournment of the meeting.
The board recommends voting in favor of all proposals, including governance changes to declassify the board and eliminate supermajority requirements.
Board of directors and corporate governance
The board will reduce from 12 to 9 members after the 2025 meeting, with three directors retiring or not standing for reelection.
The board is committed to diversity, independence, and regular refreshment, with new director selection criteria emphasizing varied backgrounds and skills.
Amendments to declassify the board and eliminate supermajority voting are proposed, aligning with shareholder feedback and governance best practices.
The board maintains four standing committees: Audit, Compensation, Corporate Governance and Nominating, and Capital Allocation.
Latest events from Sleep Number
- Proxy seeks board declassification, equity plan expansion, and governance modernization.SNBR
Proxy filing24 Mar 2026 - Turnaround strategy and cost reductions set the stage for growth and free cash flow in 2026.SNBR
Investor presentation12 Mar 2026 - Cost savings and new products drive turnaround, setting up double-digit EBITDA growth for 2026.SNBR
Q4 202512 Mar 2026 - Gross margin and cost improvements offset sales declines, supporting full-year EBITDA guidance.SNBR
Q2 20242 Feb 2026 - Gross margin hit a three-year high as cost cuts offset a 10% sales decline in Q3.SNBR
Q3 202417 Jan 2026 - Major transformation underway with cost cuts, new products, and a focus on value-driven growth.SNBR
28th Annual ICR Conference 202613 Jan 2026 - Transformation plan targets growth, efficiency, and strong free cash flow in 2026.SNBR
Investor presentation13 Jan 2026 - Gross margin gains and cost cuts drove Q4 EBITDA up 43% despite double-digit sales declines.SNBR
Q4 202425 Dec 2025 - Q1 2025 sales dropped 16% with a $8.6–$9M net loss, but gross margin rose to 61.2%.SNBR
Q1 202523 Dec 2025